Herbs (Global Traditional) · Traditional Chinese Medicine
Schisandra chinensis
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Schisandra chinensis is a traditional Chinese medicinal berry containing lignans like schisandrin that supports liver function through hepatoprotective mechanisms. The fruit demonstrates clinical efficacy in reducing menopausal symptoms and enhancing muscle strength through adaptogenic pathways.
Schisandra chinensis is a deciduous woody vine native to East Asia, particularly China, Russia, and Korea, belonging to the Magnoliaceae family. The medicinal preparation comes from its ripe red berries (called magnolia berries or wu wei zi), typically extracted using ethanol or water to concentrate its dibenzocyclooctadiene lignans and polysaccharides.
Clinical evidence includes a randomized, double-blind, placebo-controlled trial (PMID: 27763802) evaluating BMO-30 extract for menopausal symptoms from January 2014 to January 2015, and another double-blind study assessing effects on muscle strength in women. While hundreds of preclinical studies confirm adaptogenic, CNS stimulatory, and hepatoprotective effects, the research notes that most evidence is preclinical and lacks extensive RCTs or meta-analyses.
Clinically studied forms include ethanol extracts like BMO-30 for menopausal symptoms, though specific human dosages were not detailed in trials. Preclinical studies used oral doses of 50 mg/kg every other day in mice, with minimal toxic dose at 3.6 g/kg. Standardization often targets lignan content such as schisandrin and gomisin A. Consult a healthcare provider before starting any new supplement.
Schisandra chinensis (Wu Wei Zi) is not consumed as a macronutrient food source but rather as a medicinal herb valued for its dense bioactive compound profile. **Key Bioactive Compounds:** • **Lignans (Schisandrins):** The primary active constituents, collectively termed 'schisandrins' or 'schizandrins,' typically comprising 7–19% of dried fruit extract weight. Major lignans include: – Schisandrin A (Deoxyschisandrin): ~0.3–1.2% of dried fruit – Schisandrin B (γ-Schisandrin): ~0.5–1.5% of dried fruit; considered the most pharmacologically potent lignan with strong hepatoprotective and antioxidant activity – Schisandrin C: ~0.1–0.4% of dried fruit – Schisandrol A (Schisandrin): ~0.8–2.0% of dried fruit – Schisandrol B (Gomisin A): ~0.3–0.8% of dried fruit – Schisantherin A & B: trace to ~0.5% • **Organic Acids:** Citric acid (~10–12% of dried fruit), malic acid (~5–8%), tartaric acid, and fumaric acid contribute to the characteristic sour taste and may support metabolic processes. • **Essential Oils:** ~1.5–3.0% of dried fruit, containing sesquiterpenes (α-ylangene, β-chamigrene, β-himachalene) and monoterpenes (citral, borneol). • **Polysaccharides:** ~2–5% of dried fruit; display immunomodulatory and antioxidant properties in preclinical studies. • **Vitamins:** Vitamin C (~50–90 mg per 100 g dried fruit), vitamin E (~3–8 mg per 100 g dried fruit); trace amounts of B-vitamins. • **Minerals:** Potassium (~700–1,000 mg/100 g dried fruit), magnesium (~100–200 mg/100 g), calcium (~50–150 mg/100 g), iron (~3–8 mg/100 g), manganese (~2–5 mg/100 g), zinc (~1–3 mg/100 g), selenium (trace). • **Flavonoids:** Quercetin, rutin, and hyperoside present in minor quantities (~0.1–0.5%), contributing to antioxidant capacity. • **Phytosterols:** β-sitosterol and stigmasterol in trace amounts. • **Proximate Macronutrient Composition (per 100 g dried fruit, approximate):** Carbohydrates ~60–72 g (including dietary fiber ~5–10 g), protein ~4–8 g, fat ~2–5 g (including linoleic and oleic fatty acids), moisture ~10–15 g. Caloric value ~250–300 kcal/100 g dried fruit. **Bioavailability Notes:** Schisandrin B demonstrates moderate oral bioavailability (~20–30% in animal models) due to significant first-pass hepatic metabolism; co-administration with lipid-based carriers or phospholipid complexes may enhance absorption. Lignans are primarily metabolized via CYP3A4 and CYP2C9 pathways, which is clinically relevant as schisandrins can inhibit these cytochrome P450 enzymes, potentially increasing bioavailability of co-administered drugs. Polysaccharides have low direct systemic bioavailability but exert prebiotic and immunomodulatory effects in the gastrointestinal tract. Vitamin C and organic acid content may enhance non-heme mineral absorption. Standard therapeutic dosing in TCM is 1.5–9 g dried fruit per day (decoction) or 100–500 mg standardized extract (typically standardized to ≥2–9% total schisandrins).
Schisandra's primary bioactive lignans, including schisandrin A, schisandrin B, and gomisin A, modulate the hypothalamic-pituitary-adrenal axis and enhance cellular antioxidant systems. These compounds activate Nrf2 pathways, increasing glutathione production and supporting mitochondrial function. The lignans also interact with estrogen receptors and neurotransmitter systems, contributing to hormonal balance and stress adaptation.
A randomized, double-blind, placebo-controlled trial (PMID: 27763802) involving women aged 40-70 demonstrated significant reduction in menopausal symptoms with schisandra supplementation. Clinical studies have shown improved quadriceps muscle strength and reduced lactate levels in adults following schisandra administration. However, the overall clinical evidence base remains limited, with most studies involving small sample sizes and requiring replication in larger populations.
Schisandra chinensis is generally well-tolerated, with mild gastrointestinal upset being the most commonly reported side effect. The herb may interact with cytochrome P450 enzymes, potentially affecting metabolism of medications processed through these pathways. Individuals taking anticoagulant medications should exercise caution due to potential bleeding risk enhancement. Safety during pregnancy and lactation has not been established, making supplementation inadvisable for these populations.
